{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:55:54Z","timestamp":1791921354851,"version":"4.3.4"},"reference-count":122,"publisher":"Elsevier","isbn-type":[{"value":"9780128043967","type":"print"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/bs.apha.2016.04.003","type":"book-chapter","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T11:21:37Z","timestamp":1462447297000},"page":"105-141","source":"Crossref","is-referenced-by-count":82,"title":["Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function"],"prefix":"10.1016","author":[{"given":"J.D.","family":"Imig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.apha.2016.04.003_bb0005","doi-asserted-by":"crossref","first-page":"9018","DOI":"10.1073\/pnas.0703229104","article-title":"Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo","volume":"104","author":"Ai","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2016.04.003_bb0010","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/01.STR.28.5.1066","article-title":"Role of P-450 arachidonic acid epoxygenase in the response of cerebral blood flow to glutamate in rats","volume":"28","author":"Alkayed","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/bs.apha.2016.04.003_bb0015","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1161\/01.STR.0000016332.37292.59","article-title":"Neuroprotection and P450 2C11 upregulation after experimental transient ischemic attack","volume":"33","author":"Alkayed","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/bs.apha.2016.04.003_bb0020","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/01.HYP.29.1.320","article-title":"Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide","volume":"29","author":"Alonso-Galicia","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2016.04.003_bb0025","first-page":"F790","article-title":"20-HETE agonists and antagonists in the renal circulation","volume":"277","author":"Alonso-Galicia","year":"1999","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0030","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1152\/ajpregu.00664.2001","article-title":"Role of 20-hydroxyeicosatetraeinoic acid in the renal and vasoconstrictor actions of angiotensin II","volume":"283","author":"Alonso-Galicia","year":"2002","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0035","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.CIR.0000047278.28407.C2","article-title":"Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels","volume":"107","author":"Archer","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/bs.apha.2016.04.003_bb0040","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1476-5381.2010.01093.x","article-title":"Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury","volume":"162","author":"Batchu","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0045","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/FJC.0b013e318273b007","article-title":"Epoxyeicosatrienoic acid pathway in human health and diseases","volume":"61","author":"Bellien","year":"2013","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0055","doi-asserted-by":"crossref","first-page":"H1574","DOI":"10.1152\/ajpheart.01122.2011","article-title":"11,12,20-Trihydroxy-eicosa-8(Z)-enoic acid: A selective inhibitor of 11,12-EET induced relaxations of bovine coronary and rat mesenteric arteries","volume":"302","author":"Bukhari","year":"2012","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0065","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00424-010-0804-6","article-title":"Epoxyeicosatrienoic acids and endothelium-dependent responses","volume":"459","author":"Campbell","year":"2010","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/bs.apha.2016.04.003_bb0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.RES.78.3.415","article-title":"Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors","volume":"78","author":"Campbell","year":"1996","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2016.04.003_bb0075","doi-asserted-by":"crossref","first-page":"H64","DOI":"10.1152\/ajpheart.00516.2005","article-title":"Regulation of potassium channels in coronary smooth muscle by adenoviral expression of cytochrome P-450 epoxygenase","volume":"290","author":"Campbell","year":"2006","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0080","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1006\/bbrc.2001.5167","article-title":"The CYP P450 arachidonic acid monooxygenases: From cell signaling to blood pressure regulation","volume":"285","author":"Capdevila","year":"2001","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.apha.2016.04.003_bb0085","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.ki.5002394","article-title":"Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension","volume":"72","author":"Capdevila","year":"2007","journal-title":"Kidney International"},{"issue":"7","key":"10.1016\/bs.apha.2016.04.003_bb0090","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1074\/jbc.M113.508416","article-title":"The Cyp2c44 epoxygenase regulates epithelial sodium channel activity and the blood pressure responses to increased dietary salt","volume":"289","author":"Capdevila","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2016.04.003_bb0095","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1016\/S0021-9258(18)31383-8","article-title":"Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins","volume":"268","author":"Carroll","year":"1993","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2016.04.003_bb0100","doi-asserted-by":"crossref","first-page":"F155","DOI":"10.1152\/ajprenal.00231.2005","article-title":"Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP\/PKA pathway","volume":"291","author":"Carroll","year":"2006","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0022-3565(25)11191-9","article-title":"Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites","volume":"260","author":"Carroll","year":"1992","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2016.04.003_bb0110","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1042\/CS20090459","article-title":"Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats","volume":"118","author":"Certikova Chabova","year":"2010","journal-title":"Clinical Science (London, England)"},{"issue":"3\u20134","key":"10.1016\/bs.apha.2016.04.003_bb0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.prostaglandins.2011.12.005","article-title":"20-HETE in neovascularization","volume":"98","author":"Chen","year":"2012","journal-title":"Prostaglandins & Other Lipid Mediators"},{"issue":"3","key":"10.1016\/bs.apha.2016.04.003_bb0120","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1124\/jpet.113.210120","article-title":"20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo","volume":"348","author":"Chen","year":"2014","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2016.04.003_bb0125","doi-asserted-by":"crossref","first-page":"24514","DOI":"10.1074\/jbc.M709873200","article-title":"Identification of novel endogenous cytochrome P450 arachidonate metabolites with high affinity for cannabinoid receptors","volume":"283","author":"Chen","year":"2008","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2016.04.003_bb0130","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.79.4.827","article-title":"Modulation of endothelium-dependent hyperpolarization and relaxation to acetylcholine in rat mesenteric artery by cytochrome P450 enzyme activity","volume":"79","author":"Chen","year":"1996","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2016.04.003_bb0135","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.bjp.0705640","article-title":"Epoxyeicosatrienoic acids mediate adenosine-induced vasodilation in rat preglomerular microvessels (PGMV) via A2A receptors","volume":"141","author":"Cheng","year":"2004","journal-title":"British Journal of Pharmacology"},{"issue":"7","key":"10.1016\/bs.apha.2016.04.003_bb0140","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1096\/fj.13-241927","article-title":"Vascular characterization of mice with endothelial expression of cytochrome P450 4F2","volume":"28","author":"Cheng","year":"2014","journal-title":"The FASEB Journal"},{"issue":"8","key":"10.1016\/bs.apha.2016.04.003_bb0145","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1161\/ATVBAHA.112.248344","article-title":"Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction","volume":"32","author":"Cheng","year":"2012","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0150","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1182\/blood-2007-11-126680","article-title":"An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis","volume":"111","author":"Cheranov","year":"2008","journal-title":"Blood"},{"key":"10.1016\/bs.apha.2016.04.003_bb0155","author":"ClinicalTrials.gov Identifier: NCT01762774"},{"key":"10.1016\/bs.apha.2016.04.003_bb0160","doi-asserted-by":"crossref","first-page":"F544","DOI":"10.1152\/ajprenal.2000.279.3.F544","article-title":"Angiotensin II releases 20-HETE from rat renal microvessels","volume":"279","author":"Croft","year":"2000","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0165","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1073\/pnas.261710799","article-title":"Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation","volume":"99","author":"Davis","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2016.04.003_bb0170","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1096\/fj.10-171488","article-title":"Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice","volume":"25","author":"Deng","year":"2011","journal-title":"The FASEB Journal"},{"key":"10.1016\/bs.apha.2016.04.003_bb0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.prostaglandins.2006.09.008","article-title":"Protein phosphatase 2A and Ca2+-activated K+ channels contribute to 11,12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation","volume":"83","author":"Dimitropoulou","year":"2007","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2016.04.003_bb0180","doi-asserted-by":"crossref","first-page":"F753","DOI":"10.1152\/ajprenal.00292.2013","article-title":"20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension","volume":"305","author":"Ding","year":"2013","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"6","key":"10.1016\/bs.apha.2016.04.003_bb0185","doi-asserted-by":"crossref","first-page":"H2455","DOI":"10.1152\/ajpheart.00512.2008","article-title":"Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats","volume":"295","author":"Dunn","year":"2008","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"3","key":"10.1016\/bs.apha.2016.04.003_bb0190","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00424-013-1303-3","article-title":"Endothelial control of vasodilation: Integration of myoendothelial microdomain signalling and modulation by epoxyeicosatrienoic acids","volume":"466","author":"Ellinsworth","year":"2014","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/bs.apha.2016.04.003_bb0195","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejphar.2012.04.039","article-title":"Inhibitors of 20-hydroxyeicosatetraenoic acid (20-HETE) formation attenuate the natriuretic effect of dopamine","volume":"686","author":"Fernandez","year":"2012","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0200","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/46816","article-title":"Cytochrome P450 2C is an EDHF synthase in coronary arteries","volume":"401","author":"Fisslthaler","year":"1999","journal-title":"Nature"},{"key":"10.1016\/bs.apha.2016.04.003_bb0205","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/hh2101.099268","article-title":"Cytochrome p450 and vascular homeostasis","volume":"89","author":"Fleming","year":"2001","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2016.04.003_bb0210","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.prostaglandins.2006.05.003","article-title":"Epoxyeicosatrienoic acids, cell signaling and angiogenesis","volume":"82","author":"Fleming","year":"2007","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2016.04.003_bb0215","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1161\/ATVBAHA.107.152074","article-title":"Epoxyeicosatrienoic acids regulate Trp channel dependent Ca2+ signaling and hyperpolarization in endothelial cells","volume":"27","author":"Fleming","year":"2007","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0220","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1096\/fasebj.3.9.2545495","article-title":"Endothelium-derived relaxing and contracting factors","volume":"3","author":"Furchgott","year":"1989","journal-title":"The FASEB Journal"},{"key":"10.1016\/bs.apha.2016.04.003_bb0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.CIR.0000151309.82473.59","article-title":"Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension","volume":"111","author":"Gainer","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/bs.apha.2016.04.003_bb0230","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1681\/ASN.2013090980","article-title":"Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy","volume":"26","author":"Gangadhariah","year":"2015","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1016\/bs.apha.2016.04.003_bb0235","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1152\/ajpregu.00039.2015","article-title":"Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension","volume":"309","author":"Garcia","year":"2015","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"issue":"9","key":"10.1016\/bs.apha.2016.04.003_bb9000","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/01.RES.0000018162.87285.F8","article-title":"14,15-Epoxyeicosa-5(Z)-enoic acid: A selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries","volume":"90","author":"Gauthier","year":"2002","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2016.04.003_bb0240","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.phrs.2003.09.014","article-title":"14,15-EET analogs: Characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries","volume":"49","author":"Gauthier","year":"2004","journal-title":"Pharmacological Research"},{"key":"10.1016\/bs.apha.2016.04.003_bb0245","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/01.HYP.0000091265.94045.C7","article-title":"14,15-Epoxyeicosa-5(Z)-enoic-mSI: A 14,15- and 5,6-EET antagonist in bovine coronary arteries","volume":"42","author":"Gauthier","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2016.04.003_bb0250","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1073\/pnas.081627898","article-title":"Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension","volume":"98","author":"Holla","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2016.04.003_bb0255","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.prostaglandins.2015.03.002","article-title":"Vascular actions of 20-HETE","volume":"120","author":"Hoopes","year":"2015","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2016.04.003_bb0260","doi-asserted-by":"crossref","first-page":"H2462","DOI":"10.1152\/ajpheart.2001.280.6.H2462","article-title":"EDHF mediates flow-induced dilation in skeletal muscle arterioles of female eNOS-KO mice","volume":"280","author":"Huang","year":"2001","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"7","key":"10.1016\/bs.apha.2016.04.003_bb0265","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/CS20130479","article-title":"Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition","volume":"127","author":"Hye Khan","year":"2014","journal-title":"Clinical Science (London, England)"},{"key":"10.1016\/bs.apha.2016.04.003_bb0270","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.00021.2011","article-title":"Epoxides and soluble epoxide hydrolase in cardiovascular physiology","volume":"92","author":"Imig","year":"2012","journal-title":"Physiological Reviews"},{"key":"10.1016\/bs.apha.2016.04.003_bb0275","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.prostaglandins.2013.01.002","article-title":"Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function","volume":"104\u2013105","author":"Imig","year":"2013","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2016.04.003_bb0280","first-page":"F274","article-title":"Afferent arteriolar responses to ANG II involve activation of PLA2 and modulation by lipoxygenase and P-450 pathways","volume":"273","author":"Imig","year":"1997","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0285","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fphys.2010.00157","article-title":"Development of epoxyeicosatrienoic acid analogs with in vivo anti-hypertensive actions","volume":"1","author":"Imig","year":"2010","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0290","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000051053","article-title":"Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin","volume":"38","author":"Imig","year":"2001","journal-title":"Journal of Vascular Research"},{"key":"10.1016\/bs.apha.2016.04.003_bb0295","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nrd2875","article-title":"Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases","volume":"8","author":"Imig","year":"2009","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.apha.2016.04.003_bb0300","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/01.HYP.33.1.408","article-title":"Afferent arteriolar vasodilation to the sulfonimide analog of 11,12-epoxyeicosatrienoic acid involves protein kinase A","volume":"33","author":"Imig","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2016.04.003_bb0305","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1681\/ASN.V7112364","article-title":"Actions of epoxygenase metabolites on the preglomerular vasculature","volume":"7","author":"Imig","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0310","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/01.HYP.35.1.307","article-title":"Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses","volume":"35","author":"Imig","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2016.04.003_bb0315","doi-asserted-by":"crossref","first-page":"H1879","DOI":"10.1152\/ajpheart.1994.266.5.H1879","article-title":"Cytochrome P450 inhibitors alter the afferent arteriolar response to elevations in perfusion pressure","volume":"266","author":"Imig","year":"1994","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0320","first-page":"R217","article-title":"Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles","volume":"270","author":"Imig","year":"1996","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0325","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/jpet.107.130336","article-title":"20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells","volume":"324","author":"Ishizuka","year":"2008","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2016.04.003_bb0330","doi-asserted-by":"crossref","first-page":"13565","DOI":"10.1016\/S0021-9258(19)38686-7","article-title":"Molecular cloning, expression, and enzymatic characterization of the rat kidney cytochrome P-450 arachidonic acid epoxygenase","volume":"268","author":"Karara","year":"1993","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2016.04.003_bb0335","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.yjmcc.2009.02.028","article-title":"Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells","volume":"46","author":"Katragadda","year":"2009","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0345","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/HYPERTENSIONAHA.113.01949","article-title":"An orally active epoxyeicosatrienoic acid analog attenuates kidney injury in hypertensive Dahl salt sensitive rat","volume":"62","author":"Khan","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2016.04.003_bb0350","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01213011-200501000-00002","article-title":"Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension","volume":"15","author":"King","year":"2005","journal-title":"Pharmacogenetics and Genomics"},{"key":"10.1016\/bs.apha.2016.04.003_bb0355","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-201X.2000.00638.x","article-title":"Endogenous nitric oxide and epoxyeicosatrienoic acids modulate angiotensin II-induced constriction in the rabbit afferent arteriole","volume":"168","author":"Kohagura","year":"2000","journal-title":"Acta Physiologica Scandinavica"},{"key":"10.1016\/bs.apha.2016.04.003_bb0360","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/01.CIR.0000046269.52392.14","article-title":"Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic acid in human salt-sensitive versus salt-resistant hypertension","volume":"107","author":"Laffer","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/bs.apha.2016.04.003_bb0365","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCRESAHA.107.159129","article-title":"Hydrogen peroxide inhibits cytochrome p450 epoxygenases: Interaction between two endothelium-derived hyperpolarizing factors","volume":"102","author":"Larsen","year":"2008","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2016.04.003_bb0370","doi-asserted-by":"crossref","first-page":"H491","DOI":"10.1152\/ajpheart.00927.2005","article-title":"Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: Implications for soluble epoxide hydrolase inhibition","volume":"290","author":"Larsen","year":"2006","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0375","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1096\/fj.10-160119","article-title":"Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice","volume":"24","author":"Lee","year":"2010","journal-title":"The FASEB Journal"},{"key":"10.1016\/bs.apha.2016.04.003_bb0380","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/HYPERTENSIONAHA.110.161695","article-title":"Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humans","volume":"57","author":"Lee","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2016.04.003_bb0385","doi-asserted-by":"crossref","first-page":"H1229","DOI":"10.1152\/ajpheart.00736.2001","article-title":"Role of ADP-ribose in 11,12-EET-induced activation of K(Ca) channels in coronary arterial smooth muscle cells","volume":"282","author":"Li","year":"2002","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"46","key":"10.1016\/bs.apha.2016.04.003_bb0390","doi-asserted-by":"crossref","first-page":"16747","DOI":"10.1073\/pnas.0508081102","article-title":"The antiinflammatory effect of laminar flow: The role of PPAR\u03b3, epoxyeicosatrienoic acids, and soluble epoxide hydrolase","volume":"102","author":"Liu","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"10.1016\/bs.apha.2016.04.003_bb0395","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1042\/CS20120483","article-title":"Role of the CYP4A\/20-HETE pathway in vascular dysfunction of the Dahl salt-sensitive rat","volume":"124","author":"Lukaszewicz","year":"2013","journal-title":"Clinical Science (London, England)"},{"key":"10.1016\/bs.apha.2016.04.003_bb0400","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/01.RES.72.1.126","article-title":"20-Hydroxyeicosatertraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries","volume":"72","author":"Ma","year":"1993","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2016.04.003_bb0405","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bbadis.2014.12.010","article-title":"Epoxyeicosatrienoic acids act through TRPV4-TRPC1-KCa1.1 complex to induce smooth muscle membrane hyperpolarization and relaxation in human internal mammary arteries","volume":"1852","author":"Ma","year":"2015","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.apha.2016.04.003_bb0410","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2174\/156802609788340805","article-title":"Soluble epoxide hydrolase, a target with multiple opportunities for cardiovascular drug discovery","volume":"9","author":"Marino","year":"2009","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"3","key":"10.1016\/bs.apha.2016.04.003_bb0415","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/01.HYP.0000118053.42262.71","article-title":"Role of endothelium-derived hyperpolarizing factor in ACE inhibitor-induced renal vasodilation in vivo","volume":"43","author":"Matsuda","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2016.04.003_bb0420","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/10739680500466400","article-title":"A role for heterocellular coupling and EETs in dilation of rat cremaster arteries","volume":"13","author":"McSherry","year":"2006","journal-title":"Microcirculation"},{"key":"10.1016\/bs.apha.2016.04.003_bb0425","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1096\/fj.02-0640fje","article-title":"Cytochrome P450 2C9-derived epoxyeicosatrienoic acids induce angiogenesis via cross-talk with the epidermal growth factor receptor (EGFR)","volume":"17","author":"Michaelis","year":"2003","journal-title":"The FASEB Journal"},{"key":"10.1016\/bs.apha.2016.04.003_bb0430","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","article-title":"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health","volume":"53","author":"Morisseau","year":"2013","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0435","doi-asserted-by":"crossref","first-page":"H1163","DOI":"10.1152\/ajpheart.2000.278.4.H1163","article-title":"Cerebral microvascular endothelial cell tube formation: Role of astrocytic epoxyeicosatrienoic acid release","volume":"278","author":"Munzenmaier","year":"2000","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0440","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1172\/JCI27546","article-title":"Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel","volume":"116","author":"Nakagawa","year":"2006","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.apha.2016.04.003_bb0445","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1016\/bs.apha.2016.04.003_bb0450","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-385061-4.00002-7","article-title":"Vascular pharmacology of epoxyeicosatrienoic acids","volume":"60","author":"Pfister","year":"2010","journal-title":"Advances in Pharmacology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0455","doi-asserted-by":"crossref","first-page":"29619","DOI":"10.1074\/jbc.M305385200","article-title":"11,12-Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1","volume":"278","author":"Potente","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2016.04.003_bb0460","doi-asserted-by":"crossref","first-page":"15671","DOI":"10.1074\/jbc.M110806200","article-title":"Cytochrome P450 2C9-induced endothelial cell proliferation involves induction of mitogen-activated protein (MAP) kinase phosphatase-1, inhibition of the c-Jun N-terminal kinase, and up-regulation of cyclin D1","volume":"277","author":"Potente","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2016.04.003_bb0465","doi-asserted-by":"crossref","first-page":"27138","DOI":"10.1074\/jbc.M501730200","article-title":"Characterization of 5,6- and 8,9-epoxyeicosatrienoic acids (5,6- and 8,9-EET) as potent in vivo angiogenic lipids","volume":"280","author":"Pozzi","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2016.04.003_bb0470","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1161\/01.RES.60.1.50","article-title":"Intestinal vasodilation by epoxyeicosatrienoic acids: Arachidonic acid metabolites produced by a cytochrome P450 monooxygenase","volume":"60","author":"Proctor","year":"1987","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2016.04.003_bb0475","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"Roman","year":"2002","journal-title":"Physiological Reviews"},{"key":"10.1016\/bs.apha.2016.04.003_bb0480","doi-asserted-by":"crossref","first-page":"H795","DOI":"10.1152\/ajpheart.00543.2009","article-title":"Soluble epoxide hydrolase inhibition modulates vascular remodeling","volume":"298","author":"Simpkins","year":"2010","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0485","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2353\/ajpath.2009.080544","article-title":"Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection","volume":"174","author":"Simpkins","year":"2009","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0490","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1124\/jpet.109.157545","article-title":"Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice","volume":"331","author":"Sodhi","year":"2009","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2016.04.003_bb0495","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/HYPERTENSIONAHA.110.154559","article-title":"CYP4A2-induced hypertension is 20-HETE and angiotensin II-dependent","volume":"56","author":"Sodhi","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2016.04.003_bb0500","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7827(03)00049-3","article-title":"Epoxyeicosatrienoic acids (EETs): Metabolism and biochemical function","volume":"43","author":"Spector","year":"2004","journal-title":"Progress in Lipid Research"},{"key":"10.1016\/bs.apha.2016.04.003_bb0505","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2174\/092986710790827843","article-title":"Epoxyeicosatrienoic acid analogs and vascular function","volume":"17","author":"Sudhahar","year":"2010","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/bs.apha.2016.04.003_bb0510","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fphar.2014.00239","article-title":"Inside epoxyeicosatrienoic acids and cardiovascular disease","volume":"5","author":"Tacconelli","year":"2014","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2016.04.003_bb0515","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/FJC.0000000000000094","article-title":"An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II-dependent hypertension","volume":"64","author":"Ulu","year":"2014","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0520","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1161\/01.RES.0000187474.47805.30","article-title":"Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium","volume":"97","author":"Vriens","year":"2005","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2016.04.003_bb0525","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1046\/j.1523-1755.2003.00036.x","article-title":"Contributions of nitric oxide, EDHF, and EETs to endothelium-dependent relaxation in renal afferent arterioles","volume":"63","author":"Wang","year":"2003","journal-title":"Kidney International"},{"key":"10.1016\/bs.apha.2016.04.003_bb0530","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0022-3565(24)37347-1","article-title":"Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: Characterization of selective inhibitors","volume":"284","author":"Wang","year":"1998","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2016.04.003_bb0535","doi-asserted-by":"crossref","first-page":"F540","DOI":"10.1152\/ajprenal.00127.2003","article-title":"Determinants of renal afferent arteriolar actions of bradykinin: Evidence that multiple pathways mediate responses attributed to EDHF","volume":"285","author":"Wang","year":"2003","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0540","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1124\/jpet.105.083477","article-title":"Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase\/Akt signaling pathways","volume":"314","author":"Wang","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2016.04.003_bb0545","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nature01807","article-title":"Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels","volume":"424","author":"Watanabe","year":"2003","journal-title":"Nature"},{"issue":"5","key":"10.1016\/bs.apha.2016.04.003_bb0550","doi-asserted-by":"crossref","first-page":"C1292","DOI":"10.1152\/ajpcell.00230.2008","article-title":"Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis","volume":"295","author":"Webler","year":"2008","journal-title":"American Journal of Physiology. Cell Physiology"},{"issue":"1\u20134","key":"10.1016\/bs.apha.2016.04.003_bb0555","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.prostaglandins.2011.09.001","article-title":"CYP-eicosanoids\u2014A new link between omega-3 fatty acids and cardiac disease?","volume":"96","author":"Westphal","year":"2011","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2016.04.003_bb0560","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/FJC.0b013e3181f04b1c","article-title":"20-hydroxyeicosatetraeonic acid: A new target for the treatment of hypertension","volume":"56","author":"Williams","year":"2010","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0565","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1681\/ASN.2012070714","article-title":"Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase","volume":"24","author":"Wu","year":"2013","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1\u20134","key":"10.1016\/bs.apha.2016.04.003_bb0570","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.prostaglandins.2011.06.006","article-title":"The role of 20-HETE in androgen-mediated hypertension","volume":"96","author":"Wu","year":"2011","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2016.04.003_bb0580","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.abb.2009.05.006","article-title":"The arachidonic acid epoxygenase is a component of the signaling mechanisms responsible for VEGF-stimulated angiogenesis","volume":"489","author":"Yang","year":"2009","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/bs.apha.2016.04.003_bb0585","doi-asserted-by":"crossref","first-page":"36059","DOI":"10.1074\/jbc.R100030200","article-title":"Epoxygenase pathways of arachidonic acid metabolism","volume":"276","author":"Zeldin","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2016.04.003_bb0590","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1074\/jbc.M503945200","article-title":"Fibroblast growth factor-2 is a downstream mediator of phosphatidylinositol 3-kinase-Akt signaling in 14,15-epoxyeicosatrienoic acid-induced angiogenesis","volume":"281","author":"Zhang","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2016.04.003_bb0595","doi-asserted-by":"crossref","first-page":"R188","DOI":"10.1152\/ajpregu.00018.2004","article-title":"Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats","volume":"288","author":"Zhao","year":"2005","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0600","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1124\/jpet.104.070797","article-title":"P2X receptor stimulated calcium responses in preglomerular smooth muscle cells involves 20-hydroxyeicosatetraenoic acid","volume":"311","author":"Zhao","year":"2004","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2016.04.003_bb0605","doi-asserted-by":"crossref","first-page":"H2089","DOI":"10.1152\/ajpheart.2001.281.5.H2089","article-title":"The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction","volume":"281","author":"Zhao","year":"2001","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0610","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/01.HYP.0000047877.36743.FA","article-title":"Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with salt-sensitive hypertension","volume":"41","author":"Zhao","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2016.04.003_bb0615","first-page":"1244","article-title":"Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage","volume":"15","author":"Zhao","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0620","first-page":"R228","article-title":"20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles","volume":"270","author":"Zou","year":"1996","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/bs.apha.2016.04.003_bb0625","doi-asserted-by":"crossref","first-page":"F275","DOI":"10.1152\/ajprenal.1994.266.2.F275","article-title":"Inhibition of renal vascular 20-HETE impairs autoregulation of renal blood flow","volume":"266","author":"Zou","year":"1994","journal-title":"American Journal of Physiology. Renal Physiology"}],"container-title":["Advances in Pharmacology","Endothelium"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358916300266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358916300266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T20:53:18Z","timestamp":1748897598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358916300266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9780128043967"],"references-count":122,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2016.04.003","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}